E70K is a point-modified peptide or protein fragment featuring a glutamate-to-lysine substitution that alters charge distribution and electrostatic interactions. This mutation introduces a basic side chain, reshaping local hydrogen-bond patterns and structural propensity. Researchers use it to evaluate mutation-driven conformational changes and binding specificity. Applications include structure-function mapping, electrostatic surface analysis, and protein-engineering investigations.
CAT No: R2796
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More